BYAH
Park Ha Biological Technology Co., Ltd. Ordinary Shares
There isn't enough reported data to score BYAH yet.
LCID
Lucid Group, Inc.
LCID lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
BYAH Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Weak | |
| Strong |
BYAH's revenue and balance sheet are currently strong, but its profitability and cash flow are weak.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
BYAH PE Valuation
BYAH has no meaningful PE right now: it lost money over the past year.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
BYAH Forward outlook
There aren't enough analyst estimates for BYAH to show an outlook.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
BYAH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | -$506.83 | -5133% |
| Q3 2025 | -$440.10 | -4979% |
| Q2 2025 | -$408.34 | -4961% |
| Q1 2025 | -$137.87 | -1248% |
| Q4 2024 | $10.07 | -36% |
LCID has the stronger earnings trend. Trailing diluted EPS is down 5,133% for BYAH versus LCID down 224%.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
BYAH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.3M | +1.5% |
| Q4 2025 | $1.3M | -16% |
| Q3 2025 | $642.8K | -16% |
| Q2 2025 | $1.2M | +45% |
| Q4 2024 | $1.5M | +41% |
| Q3 2024 | $764.5K | +41% |
| Q2 2024 | $852.9K | -38% |
| Q1 2024 | $426.5K | -38% |
LCID has the stronger quarterly revenue trend. Revenue is up 1.5% for BYAH versus up 4.1% for LCID.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -77% | +1515 points |
| Q1 2026 | -77% | N/A |
| Q4 2025 | -345% | -391 points |
| Q3 2025 | -345% | -391 points |
| Q2 2025 | -1591% | -1602 points |
| Q4 2024 | 46% | -0.6 points |
| Q3 2024 | 46% | -0.6 points |
| Q2 2024 | 11% | -38 points |
BYAH's operating margin was −77% last quarter, up 1514 points from the same quarter a year ago.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID's revenue has grown year over year for 11 quarters in a row: $350M last quarter, up 4.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
BYAH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$338.8K | -239% |
| Q1 2026 | -$169.4K | -239% |
| Q4 2025 | -$246.2K | -129% |
| Q3 2025 | -$123.1K | -129% |
LCID has the stronger cash trend. Its trailing FCF is down 75% versus its history, compared with BYAH at down 245%.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
BYAH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -7% | -5.6K shares |
| 1 year | +1.3% | +936 shares |
BYAH has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
BYAH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2025 | -0.4x | Net Cash |
| Q4 2024 | -0.4x | Net Cash |
| Q3 2024 | -0.5x | Net Cash |
| Q2 2024 | -1.0x | Net Cash |
BYAH has more cash than debt.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BYAH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 13.0 | Oversold |
| Stochastic | 4.7 | Oversold |
BYAH's weekly RSI is 13 (oversold) and its Stochastic is 5 (oversold).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
BYAH PE vs Consumer Cyclical Sector
BYAH has no meaningful PE right now: it lost money over the past year.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
BYAH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.25 | 35% below |
| 20 week MA | $2.93 | 50% below |
| 50 week MA | $18.5 | 92% below |
LCID has stronger trend alignment. BYAH is above 0 of 3 weekly averages versus LCID above 0 of 5.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
BYAH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $193.2 | $73.2 | -62% |
| 2026 YTD | $73.2 | $1.47 | -98% |
BYAH has finished every year since 2025 lower, and it's down 98% so far in 2026.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has the edge over BYAH on returns for 2026, with the stronger performance.